Armata Pharmaceuticals, Inc. 10-Q filing
Filed 2025-11-12 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001104659-25-110383
- Form type
- 10-Q
- CIK
- 0000921114
- Primary document
- https://www.sec.gov/Archives/edgar/data/921114/000110465925110383/armp-20250930x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Armata Pharmaceuticals, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-22.8M | - | - |
| Net Income | $-49.5M | - | - |
| Eps Basic | -1.37 | - | - |
| Eps Diluted | -1.37 | - | - |
| Cash And Equivalents | $14.8M | - | - |
| Total Assets | $89.5M | - | - |
| Total Liabilities | $185.1M | - | - |
| Shareholders Equity | $-95.6M | - | - |
| Operating Cash Flow | $-19.1M | - | - |
| Capital Expenditures | $490,000 | - | - |